Skip to content

Public FDA record

Z-1519-06: Anti-CD45 Cocktail antibody in 6 ml vials; Cat. No. AM371-5M , manufactured and distributed by BioGenex,

Recall record Z-1519-06 for Biogenex Laboratories. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1519-06
Company in FDA record
Biogenex Laboratories
FDA classification date
Sep 23, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Mislabeling: Anti-CD45 cocktail antibody mislabeled as Ki-67.

Source facts

Action
On 9/5/06, the firm issued a notification letter to the consignees with a correct label to apply, and a return the reply form included with the letter.
Initiated
2006-09-05
Root cause
Other
Terminated
2006-11-17
Distribution
Worldwide distribution --- including state of Texas and countries of Amman, Jordan, and India.
Recall number
Z-1519-06
Recall status
Terminated
CDRH record ID
48267
FDA classified
2006-09-23
Recall event number
36259

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗